Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
about
HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" studyFrailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection.Zidovudine and Lamivudine for HIV Infection.Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionSafety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infantsAntiretroviral neurotoxicityImpact of age on markers of HIV-1 diseaseRole of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome.Mitochondrial toxicity and caspase activation in HIV pregnant women.Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Molecular mechanisms for insulin resistance in treated HIV-infection.Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patientsChanges in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients.Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.PharmGKB summary: zidovudine pathwayMitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infection.Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults.Association Between Health-Related Quality of Life and Physical Functioning in Antiretroviral-Naive HIV-Infected PatientsExamining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q28729025-B3A506EF-3EF5-49CA-8DEA-0179D8190F04Q30248351-190563C5-16B9-4B2D-9DB8-FAD135973454Q33600363-39B59707-87C4-429B-87A3-00A0288B5150Q34001786-DDF42735-715F-4D64-BBCD-968E6B70E59FQ34194561-474798F3-F08B-422C-88C9-742FCCC2D072Q34481359-F69B3511-C787-4B0F-9F14-5D5F341D5F4BQ36333957-B7525DBD-4411-436A-958D-5B78C5675AC3Q36635673-20E7D5BD-C7DE-47DD-BE11-8AEEF5AD1F7CQ36763762-E55CE7D0-1898-46D4-82DD-36351645B535Q37077573-AF225511-9511-42C0-AB9D-0C3BDCEB4A89Q37539856-6C90EC62-DDC3-4797-A2CC-C7AF7768C4F0Q37694939-A4696201-97C7-46EF-9CCF-CD20CE8EFF37Q37835819-15F21CFF-C4A0-48A1-9226-582B5672C627Q37887885-E40D9268-BA3B-4F46-B507-E6AFC0FCF86FQ39116610-B6862692-36E7-40FC-AD36-1812616B6218Q39877513-86A9DBBB-D341-4BD9-BA4D-A3D097746FEEQ40212933-D97F6239-DFD8-4537-9474-9AE743F75D3FQ41474530-922C4908-0D72-4282-AA7C-1C7B83947140Q43035090-7F1D2A75-4D76-4C89-B031-D140BDA3DD47Q45358296-D2CE62D2-C5FA-4B18-A2E6-8054141361B5Q55169028-FF3DB8EB-B78F-4185-A19C-5629F00D34CEQ58126379-F3C993B8-9692-462C-BC1C-8CE1A4663CB5Q58549748-57833479-9C4D-4F7D-A5C4-71A88D2AC21A
P2860
Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@en
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@nl
type
label
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@en
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@nl
prefLabel
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@en
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@nl
P921
P356
P1476
Mitochondrial toxicity in HIV- ...... istinct underlying mechanisms?
@en
P2093
Anne Maagaard
P304
P356
10.1093/JAC/DKP316
P407
P50
P577
2009-09-09T00:00:00Z